BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9204410)

  • 1. Role of the liver-enriched transcription factors C/EBP alpha and DBP in the expression of human CYP3A4 and CYP3A7.
    Ourlin JC; Jounaïdi Y; Maurel P; Vilarem MJ
    J Hepatol; 1997; 26 Suppl 2():54-62. PubMed ID: 9204410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma.
    Rodríguez-Antona C; Bort R; Jover R; Tindberg N; Ingelman-Sundberg M; Gómez-Lechón MJ; Castell JV
    Mol Pharmacol; 2003 May; 63(5):1180-9. PubMed ID: 12695546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element.
    Saito T; Takahashi Y; Hashimoto H; Kamataki T
    J Biol Chem; 2001 Oct; 276(41):38010-22. PubMed ID: 11495920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.
    Lacroix D; Sonnier M; Moncion A; Cheron G; Cresteil T
    Eur J Biochem; 1997 Jul; 247(2):625-34. PubMed ID: 9266706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CYP3A7 gene induction by 1,25-dihydroxyvitamin D3 is caused by less binding of VDR to the proximal ER6 in CYP3A7 gene.
    Hara H; Yasunami Y; Adachi T
    Biochem Biophys Res Commun; 2004 Sep; 321(4):909-15. PubMed ID: 15358113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.
    Goodwin B; Hodgson E; Liddle C
    Mol Pharmacol; 1999 Dec; 56(6):1329-39. PubMed ID: 10570062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein-alpha-dependent transactivation of CYP2C12 in rat hepatocytes.
    Tollet P; Lahuna O; Ahlgren R; Mode A; Gustafsson JA
    Mol Endocrinol; 1995 Dec; 9(12):1771-81. PubMed ID: 8614413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control.
    Hashimoto H; Toide K; Kitamura R; Fujita M; Tagawa S; Itoh S; Kamataki T
    Eur J Biochem; 1993 Dec; 218(2):585-95. PubMed ID: 8269949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
    Burk O; Tegude H; Koch I; Hustert E; Wolbold R; Glaeser H; Klein K; Fromm MF; Nuessler AK; Neuhaus P; Zanger UM; Eichelbaum M; Wojnowski L
    J Biol Chem; 2002 Jul; 277(27):24280-8. PubMed ID: 11940601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family.
    Riffel AK; Schuenemann E; Vyhlidal CA
    Mol Pharmacol; 2009 Nov; 76(5):1104-14. PubMed ID: 19706729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Sp1, C/EBP alpha, HNF3, and PXR in the basal- and xenobiotic-mediated regulation of the CYP3A4 gene.
    Bombail V; Taylor K; Gibson GG; Plant N
    Drug Metab Dispos; 2004 May; 32(5):525-35. PubMed ID: 15100175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).
    Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
    Mol Pharmacol; 2005 Jun; 67(6):2088-101. PubMed ID: 15778453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7.
    Bertilsson G; Berkenstam A; Blomquist P
    Biochem Biophys Res Commun; 2001 Jan; 280(1):139-44. PubMed ID: 11162490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
    Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
    Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture.
    Greuet J; Pichard L; Bonfils C; Domergue J; Maurel P
    Biochem Biophys Res Commun; 1996 Aug; 225(2):689-94. PubMed ID: 8753820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
    Schuetz JD; Kauma S; Guzelian PS
    J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes.
    Baumann H; Morella KK; Campos SP; Cao Z; Jahreis GP
    J Biol Chem; 1992 Sep; 267(27):19744-51. PubMed ID: 1382074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the human reduced folate carrier promoter C: synergistic transactivation by Sp1 and C/EBP beta and identification of a downstream repressor.
    Payton SG; Whetstine JR; Ge Y; Matherly LH
    Biochim Biophys Acta; 2005 Jan; 1727(1):45-57. PubMed ID: 15652157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/enhancer-binding protein beta (C/EBP beta) binds and activates while hepatocyte nuclear factor-4 (HNF-4) does not bind but represses the liver-type arginase promoter.
    Chowdhury S; Gotoh T; Mori M; Takiguchi M
    Eur J Biochem; 1996 Mar; 236(2):500-9. PubMed ID: 8612622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPalpha (CCAAT/enhancer-binding protein alpha)-stimulated expression of the sex-specific cytochrome P450 2C12 gene.
    Buggs C; Nasrin N; Mode A; Tollet P; Zhao HF; Gustafsson JA; Alexander-Bridges M
    Mol Endocrinol; 1998 Sep; 12(9):1294-309. PubMed ID: 9731699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.